Clinical Trial Update: Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial evaluating azilsartan medoxomil (TAK-491) in Korean adults with hypertension; results from the study were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Azilsartan medoxomil (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-12-19